Fundraising Fox

The E14 Fund2022 Investments

4 investments dated 2022 · listed companies and verified rows first · show all

Atlantic Quantumatlantic-quantum.comMay 2022

Building scalable quantum computers with reduced complexity and cost to reach error correction at scale.

Cambridge, US

Bharath Kannan(Executive Officer)Simon Gustavsson(Director)

Co-investorsBlindspot Ventures Management CoChalmers Ventures ABMassVenturesNeotribe VenturesThe Engine VenturesGlasswing Ventures

Brelyonbrelyon.comin𝕏May 2022

Brelyon develops headset-free virtual displays using optical and computational techniques to create 3D depth and panoramic imagery for gaming, entertainment, and enterprise applications.

AI & Machine LearningDeep TechHardwareSan Mateo, US

Barmak Heshmat Dekhordi(Executive Officer, Director)Alok Mehta(Director)

BoardCalvin Chin(Director)in

Co-investorsLG Technology VenturesLockheed Martin VenturesGrit VenturesMonozukuri VenturesOne Way VenturesType One Ventures+1 more

Replitreplit.comin𝕏Mar 2022

Replit is a platform for software development that aims to make app creation accessible to non-programmers through intuitive tools and AI agents.

AI & Machine LearningCloud ComputingCreator EconomyDeveloper ToolsEdTechEnterprise SoftwareSan Francisco, US

Haya Abdalla(Founder)inAmjad Masad(Founder)inHaya Odeh(Co-Founder, Design)inLuis Héctor Chávez(CTO)

Co-investors137 Ventures7BC Venture CapitalA.Capital VenturesAbstract VenturesAllied Venture PartnersAmino Capital+29 more

Volta Labs, Inc.voltalabs.comin𝕏Jan 2022

Volta develops a hardware and software platform for genomics sample preparation that automates the extraction of biological information.

AI & Machine LearningBiotechDeep TechHardwareHealthtechMedical DevicesRoboticsBoston, US

Udayan Umapathi(Founder)in

BoardNatan Linder(Director)David Singer(Director)Maxim Lobovsky(Director)

Co-investorsBlindspot Ventures Management CoY CombinatorVillage Global

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.